AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

GALT · NASDAQ · Biotechnology

Galectin Therapeutics (GALT)

Develops belapectin, a galectin-3 inhibitor, for MASH cirrhosis with portal hypertension.

$4.35

Pre-market−0.14 (−3.12%)

At close$4.49(+7.67%)

Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Institutions107 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail	≈ 15.62%	15.75M shares
Insiders8 holders · as of Aug 4, 2026	56.27%	56.75M shares
Strategic holders1 holder · as of Dec 18, 2025	5.57%	5.61M shares
Otherremainder	≈ 22.54%	22.73M shares

100.85M company shares as of Sep 3, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

Two share counts disagree (100.85M in the company's Sep 3, 2026 report, 65.86M elsewhere); stakes use the report.

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

Top shareholders13F · 13D/G · Form 4

Holder	Stake	Shares	Evidence
Richard E. UihleinInsiderdirector, 10 percent owner	54.21%	54.67M	13Dfiled Aug 4, 2026 ↗
10X Fund, L.P.Strategic10 percent owner	5.57%	5.61M	Form 4filed Dec 18, 2025 ↗
BlackRock, Inc.Institution	2.96%	2.99M	13Fas of Jun 30, 2026
Vanguard Capital Management LLCInstitution	2.15%	2.17M	13Fas of Jun 30, 2026
Geode Capital Management, LLCInstitution	1.30%	1.31M	13Fas of Jun 30, 2026
Advisor Group Holdings, Inc.Institution	1.19%	1.20M	13Fas of Jun 30, 2026
James C. CzirrInsider10 percent owner	1.04%	1.05M	Form 4filed Jun 11, 2025 ↗
Marshall Wace, LLPInstitution	0.82%	831,010	13Fas of Jun 30, 2026
Joel LewisInsiderdirector, officer: President and CEO	0.77%	776,260	Form 4filed Jan 13, 2026 ↗
Wealthspire Advisors, LLCInstitution	0.72%	721,788	13Fas of Jun 30, 2026
State Street CorpInstitution	0.56%	567,779	13Fas of Jun 30, 2026
Commonwealth Equity Services, LLCInstitution	0.40%	407,113	13Fas of Jun 30, 2026
Northern Trust CorpInstitution	0.38%	386,545	13Fas of Jun 30, 2026
Vanguard Fiduciary Trust CoInstitution	0.36%	366,476	13Fas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution	0.33%	327,766	13Fas of Jun 30, 2026
Two Sigma Investments, LPInstitution	0.32%	318,245	13Fas of Jun 30, 2026
LPL Financial LLCInstitution	0.28%	285,380	13Fas of Jun 30, 2026
Sovran Advisors, LLCInstitution	0.26%	257,997	13Fas of Jun 30, 2026
Geneos Wealth Management Inc.Institution	0.24%	240,427	13Fas of Jun 30, 2026
UBS Group AGInstitution	0.22%	219,319	13Fas of Jun 30, 2026
Retirement Guys Formula LLCInstitution	0.21%	211,053	13Fas of Jun 30, 2026
Citadel Advisors LLCInstitution	0.20%	198,701	13Fas of Jun 30, 2026
Susquehanna International Group, LLPInstitution	0.18%	177,197	13Fas of Jun 30, 2026
National Bank of Canada /FI/Institution	0.17%	167,900	13Fas of Jun 30, 2026
Blair William & Co/ILInstitution	0.15%	149,283	13Fas of Jun 30, 2026

13F — a manager's quarterly holdings · 13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F, as of Jun 30, 2026

107 holders · 15.75M shares · 21 new positions · 55 increased · 23 reduced · 19 closed

Holder	Shares	% outstanding	Chg q/q	Filed
BlackRock, Inc.	2.99M	2.96%	+2.19M	Aug 7, 2026
Vanguard Capital Management LLC	2.17M	2.15%	+201.5K	Aug 13, 2026
Geode Capital Management, LLC	1.31M	1.30%	+695.6K	Aug 12, 2026
Advisor Group Holdings, Inc.	1.20M	1.19%	+81.1K	Aug 14, 2026
Marshall Wace, LLP	831.0K	0.82%	−388.9K	Aug 13, 2026
Wealthspire Advisors, LLC	721.8K	0.72%	0	Aug 11, 2026
State Street Corp	567.8K	0.56%	+309.3K	Aug 7, 2026
Commonwealth Equity Services, LLC	407.1K	0.40%	+40.0K	Jul 29, 2026

Ownership statements13D/G · 5% or more, as filed

Holder	% of class	Shares	Form	Filed
Richard E. Uihlein	49.30%	54.67M	13D	Aug 4, 2026 ↗

Insider tradesForm 4

Latest trades

Date	Insider	Type	Shares	Avg price	Owned after
Jul 14, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	16,250	$5.13	0
Jun 29, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	47,467	$5.04	0
Jun 26, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	2,533	$5.00	0
Jun 26, 2026	Harold H. Shlevindirector	Sale	7,732	$5.00	6,500
Jun 29, 2026	Harold H. Shlevindirector	Sale	22,268	$5.04	6,500
Jun 23, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	7,557	$3.14	0
May 26, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	568	$3.10	0
Feb 6, 2026	Kary Eldreddirector	Purchase	300	$2.70	65,682
Jan 6, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	21,446	$3.65	0
Jan 5, 2026	Khurram Jamilofficer: Chief Medical Officer	Sale	25,499	$3.90	21,446

CongressHouse and Senate disclosures

Not reported.